Table of Contents

company-logo

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Esperion Therapeutics Dividend Announcement

• Esperion Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Esperion Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Esperion Therapeutics Dividend History

Esperion Therapeutics Dividend Yield

Esperion Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Esperion Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Esperion Therapeutics Financial Ratios

P/E ratio-5.05
PEG ratio-1.62
P/B ratio-1.18
ROE23.71%
Payout ratio0.00%
Current ratio1.85
Quick ratio1.37
Cash Ratio0.87

Esperion Therapeutics Dividend FAQ

Does Esperion Therapeutics stock pay dividends?
Esperion Therapeutics does not currently pay dividends to its shareholders.
Has Esperion Therapeutics ever paid a dividend?
No, Esperion Therapeutics has no a history of paying dividends to its shareholders. Esperion Therapeutics is not known for its dividend payments.
Why doesn't Esperion Therapeutics pay dividends?
There are several potential reasons why Esperion Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Esperion Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Esperion Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Esperion Therapeutics a dividend aristocrat?
Esperion Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Esperion Therapeutics a dividend king?
Esperion Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Esperion Therapeutics a dividend stock?
No, Esperion Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Esperion Therapeutics stocks?
To buy Esperion Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Esperion Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.